QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III tria 期刊论文 2019 作者:  Guo Y;  Ahn M-J;  Chan A;  Wang C-H;  Kang J-H 收藏  |  浏览/下载：39/0  |  提交时间：2020/01/03 Asian  HNSCC  afatinib  methotrexate   The Effectiveness of Sorafenib over Other Targeted Agents in the Second-Line Treatment of Metastatic Renal Cell Carcinoma: a Meta-Analysis 期刊论文 2018 作者:  Huang Hou-Feng;  Fan Xin-Rong;  Ji Zhi-Gang 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Meta-analysis  Metastatic renal cell carcinoma  Second-line therapy  Sorafenib   Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China 期刊论文 2018, 卷号: 18 作者:  Chen, Junli;  Zhang, Min;  Shang, Mingquan;  Yang, Weiwei;  Wang, Zhe 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 HIV-1  HAART  Second-line antiretroviral therapy  CD4 count  Viral load  Drug resistance   Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) 期刊论文 2016, 卷号: 27, 期号: 3, 页码: 441-448 作者:  Motzer, R. J.;  Alyasova, A.;  Ye, D.;  Karpenko, A.;  Li, H. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 everolimus  metastatic renal cell carcinoma  sequential targeted therapy  second-line  prospective study   Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patients 期刊论文 2015, 卷号: 10, 期号: 3, 页码: e0120705 作者:  Han Yang;  Li Yijia;  Xie Jing;  Qiu Zhifeng;  Li Yanling 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20 作者:  Qin, Shukui;  Bi, Feng;  Cheng, Ying;  Guo, Jun;  Ren, Xiu Bao 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. 期刊论文 2012, 卷号: 30, 期号: 15 作者:  Qin, Shukui;  Bi, Feng;  Cheng, Ying;  Guo, Jun;  Ren, Xiu Bao 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13